Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
19:50:50 EDT Thu 15 Oct 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

News for U:NUWE from 2025-10-16 to 2026-10-15 - 50 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2026-10-08 08:30U:NUWENews ReleaseNuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian(TM) Pediatric CRRT System
2026-10-01 08:30U:NUWENews ReleaseNuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical Conferences
2026-09-17 08:30U:NUWENews ReleaseNuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue Opportunity
2026-09-16 08:30U:NUWENews ReleaseNuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory Affairs
2026-09-09 08:30U:NUWENews ReleaseNuwellis Advances Financial Efficiency Strategy with Improved Gross Margins
2026-08-25 08:30U:NUWENews ReleaseNuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical
2026-08-13 08:00U:NUWENews ReleaseNuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin
2026-08-11 03:30U:NUWENews ReleaseNuwellis Accelerates Digital Transformation of the Aquadex(TM) Platform with EHR Connectivity and Enhanced User Interface
2026-08-06 08:30U:NUWENews ReleaseNuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer
2026-08-04 08:30U:NUWENews ReleaseNuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications
2026-07-31 08:39U:NUWENews ReleaseNuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
2026-07-30 08:00U:NUWENews ReleaseNuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy
2026-07-28 08:00U:NUWENews ReleaseNuwellis Expands Pediatric Footprint with First Aquadex SmartFlow(TM) Installations in Wisconsin
2026-07-27 08:30U:NUWENews ReleaseNuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth
2026-07-16 08:30U:NUWENews ReleaseNuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies
2026-07-07 08:00U:NUWENews ReleaseNuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026
2026-06-26 08:00U:NUWENews ReleaseNuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC(sup4))
2026-06-25 08:30U:NUWENews ReleaseNuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow(TM) Installations
2026-06-24 08:30U:NUWENews ReleaseIncoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders
2026-06-18 08:30U:NUWENews ReleaseNuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit
2026-06-16 08:30U:NUWENews ReleaseNuwellis Appoints Mike McCormick as Chief Executive Officer
2026-06-10 08:30U:NUWENews ReleaseNuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow(TM) Devices at One of its Children's Hospitals
2026-06-08 21:47U:NUWENews ReleaseNuwellis Announces Closing of $6.0 Million Registered Public Offering
2026-06-05 08:30U:NUWENews ReleaseNuwellis Announces Pricing of $6 Million Public Offering
2026-05-14 08:30U:NUWENews ReleaseNuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label
2026-05-12 08:00U:NUWENews ReleaseNuwellis, Inc. Announces First Quarter 2026 Financial Results
2026-05-05 08:00U:NUWENews ReleaseNuwellis, Inc. To Announce First Quarter 2026 Financial Results on May 12, 2026
2026-04-29 08:30U:NUWENews ReleaseNuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting
2026-04-28 08:30U:NUWENews ReleaseNuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology
2026-04-23 08:30U:NUWENews ReleaseNuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat
2026-04-21 08:30U:NUWENews ReleaseNuwellis Announces Aquadex Software Update
2026-04-16 08:30U:NUWENews ReleaseNuwellis Welcomes Back Three Former Team Members to Accelerate Commercial and Clinical Momentum
2026-04-09 08:30U:NUWENews ReleaseNuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services
2026-04-07 08:30U:NUWENews ReleaseNuwellis Strengthens Commercial Infrastructure with New South Texas Territory
2026-03-31 08:30U:NUWENews ReleaseNuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone
2026-03-17 08:00U:NUWENews ReleaseNuwellis Completes Acquisition of Rendiatech
2026-03-10 08:15U:NUWENews ReleaseNuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
2026-03-05 08:00U:NUWENews ReleaseNuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy
2026-02-26 08:00U:NUWENews ReleaseNuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors
2026-02-24 08:00U:NUWENews ReleaseNuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
2026-01-30 08:00U:NUWENews ReleaseNuwellis Appoints Carisa Schultz as Chief Financial Officer
2026-01-29 16:36U:NUWENews ReleaseNuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market
2026-01-29 16:35U:NUWENews ReleaseNuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy
2026-01-23 16:40U:NUWENews ReleaseNuwellis Announces Changes to Board of Directors
2026-01-06 08:15U:NUWENews ReleaseNuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy
2025-12-09 08:15U:NUWENews ReleaseLenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings
2025-12-04 08:15U:NUWENews ReleaseNuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.
2025-11-12 08:15U:NUWENews ReleaseNuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum
2025-11-10 09:00U:NUWENews ReleaseNuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian(TM) Pediatric System with Advanced Clamp Safety Technology
2025-10-23 09:00U:NUWENews ReleaseNuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025